News

Home/News
News 2017-06-21T13:15:59+00:00
June 22, 2018
UK's MHRA renews Early Access to Medicines Scheme Scientific Opinion for Santhera's Raxone® (idebenone) in Duchenne Muscular Dystrophy
Pratteln, Switzerland, June 22, 2018 - Santhera Pharmaceuticals (SIX: SANN) announces that the UK`s Medicines and Healthcare products Regulatory Agency (MHRA) has renewed the Early Access to ...
June 22, 2018
Prometic Presents New Data on NASH Drug Candidate PBI-4547
LAVAL, QC, June 22, 2018 /PRNewswire/ - Prometic Life Sciences Inc. (PLI.TO) (PFSCF) (Prometic) today announced the presentation of four posters at the American Diabetes Association's 78th ...
June 22, 2018
Pernix Therapeutics Announces Result of Bid Process for Acquisition of Worldwide Rights to Contrave® for Weight Loss
MORRISTOWN, N.J., June 22, 2018 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (PTX), a specialty pharmaceutical company, today announced that Nalpropion Pharmaceuticals, Inc. (“Nalpropion”), the ...
June 22, 2018
Mustang Bio Announces Opening of CAR T Cell Therapy Manufacturing Facility in Worcester, Mass.
NEW YORK, June 22, 2018 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (MBIO), a Fortress Biotech (FBIO) Company focused on the development of novel immunotherapies ...
June 22, 2018
Lilly Completes Acquisition of ARMO BioSciences
INDIANAPOLIS, June 22, 2018 /PRNewswire/ -- Eli Lilly and Company (LLY) today announced the successful completion of its acquisition of ARMO BioSciences, Inc. (ARMO). Lilly's ...
June 21, 2018
Molecular Templates Set to Join the Russell 3000® and Russell Microcap® Indexes
AUSTIN, Texas, June 21, 2018 (GLOBE NEWSWIRE) -- Molecular Templates, Inc., (MTEM) a clinical stage biopharmaceutical company focused on the discovery and development of Engineered ...
June 21, 2018
UPDATE - PolarityTE Appoints Paul Mann of Highbridge Capital to Chief Financial Officer
SALT LAKE CITY, June 21, 2018 (GLOBE NEWSWIRE) -- PolarityTE, Inc. (COOL) today announced that Paul Mann of Highbridge Capital Management is the new Chief ...
June 20, 2018
Keryx Biopharmaceuticals Announces Participation in a Renal Disease Panel at the JMP Securities Life Sciences Conference on Thursday, June 21st
BOSTON, June 20, 2018 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (KERX), a biopharmaceutical company focused on bringing innovative medicines to people with kidney disease, today ...
June 20, 2018
INVENTIVA : FDA Approval of an Investigator Initiated IND Application to Conduct Phase II Study of Lanifibranor in Type 2 Diabetic Patients with Non-Alcoholic Fatty Liver Disease
Daix (France) June 20, 2018 - Inventiva S.A. ("Inventiva" or the "Company"), a biopharmaceutical company developing innovative therapies in nonalcoholic steatohepatitis (NASH), systemic sclerosis (SSc) ...
June 20, 2018
MannKind to Host Institutional Investor and Analyst Meeting
WESTLAKE VILLAGE, Calif., June 20, 2018 (GLOBE NEWSWIRE) -- MannKind Corporation (MNKD) today announced that it will host an invitation-only luncheon at Lotte New York ...
June 20, 2018
Reata Announces Initiation of a Phase 1 Trial of RTA 1701, a Selective, Oral Allosteric Inhibitor of RORγt
IRVING, Texas, June 20, 2018 (GLOBE NEWSWIRE) -- Reata Pharmaceuticals, Inc. (RETA), a clinical-stage biopharmaceutical company, today announced the initiation of a Phase 1 clinical ...
June 20, 2018
Oncobiologics Announces Conversion of Majority of Series A Convertible Preferred Stock
CRANBURY, N.J., June 20, 2018 (GLOBE NEWSWIRE) -- Oncobiologics, Inc. (ONS) (the “Company”) today announced that GMS Tenshi Holdings Pte. Limited (“GMS Tenshi”), the Company’s ...
June 20, 2018
Cormedix Inc. Completes Review and Source Verification of Phase 3 Lock-It 100 Data For Neutrolin(R)
BERKELEY HEIGHTS, NJ / ACCESSWIRE / June 20, 2018 / CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products ...
June 20, 2018
Paratek Announces FDA Advisory Committee Date for Omadacycline
BOSTON, June 20, 2018 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (PRTK), a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon ...
June 20, 2018
Neovasc Announces First Implant of a Neovasc Reducer™ in a U.S. Patient
VANCOUVER , June 20, 2018 /CNW/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN), a leader in the development of minimally invasive transcatheter ...
June 20, 2018
Zosano Announces Publication on Adhesive Dermally-Applied Microarray (ADAM™) Technology for the Delivery of Zolmitriptan in Migraine in Journal of Pharmaceutics
FREMONT, Calif., June 20, 2018 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (ZSAN) (“Zosano” or the “Company”), a clinical-stage biopharmaceutical company focused on providing rapid systemic administration ...
June 19, 2018
Kuros Biosciences to Present Promising Clinical Case Studies with MagnetOs at Leading Spine Surgery Conference
SCHLIEREN (ZURICH), Switzerland, June 19, 2018 (GLOBE NEWSWIRE) -- Kuros Biosciences (SIX:KURN) will this week present results from several investigator-led clinical case studies of MagnetOs ...
June 19, 2018
Celyad Doses First AML Patient at Final Dose Level in CYAD-01 THINK Trial and Begins Dosing First Patient With Second Cycle of Therapy
MONT-SAINT-GUIBERT, Belgium, June 19, 2018 (GLOBE NEWSWIRE) -- Celyad (Euronext Brussels:CYAD) (Euronext Paris:CYAD) (CYAD), a clinical-stage biopharmaceutical company focused on the development of CAR-T cell ...
June 19, 2018
MediWound Expands Its NexoBrid® Phase 3 Children Innovation Debridement Study (CIDS) to the U.S.
YAVNE, Israel, June 19, 2018 (GLOBE NEWSWIRE) -- MediWound Ltd. (MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn ...
June 19, 2018
Novus Therapeutics Receives FDA Guidance at Type C Meeting for OP-02 in the Treatment and Prevention of Otitis Media
IRVINE, Calif.--(BUSINESS WIRE)--Novus Therapeutics, Inc. (NVUS), a specialty pharmaceutical company focused on developing products for patients with disorders of the ear, nose, and throat (ENT), ...
Page 1 of 87